Symbravo™: A New Breakthrough for Migraine Relief – What You Should Know

Migraine is a powerful and disabling condition that affects millions of people. Many in the migraine community have shared their struggles with finding treatments that bring fast and lasting relief, and in 2025, the FDA approved a new medication called Symbravo. Below, we break down what makes Symbravo™ unique, how it works, the benefits and risks, and why it represents hope for people living with migraine. Read on to learn more about what Symbravo is and why it may be worth taking a look at!

Symbravo is an acute prescription medication for adults used during a migraine attack (with or without aura). It is not meant to prevent migraines or treat other types of headaches, such as cluster headaches. Each Symbravo tablet contains two medicines: 20 mg of meloxicam (a nonsteroidal anti-inflammatory drug, or NSAID) and 10 mg of rizatriptan (a triptan that relieves headache symptoms). You take just 1 tablet as soon as a migraine strikes. Most people do not need a second dose, and using more than one tablet in 24 hours is not recommended.

How Does Symbravo Work?

Symbravo is different from other migraine medicines because it combines two powerful treatments:

• Meloxicam: This NSAID eases pain and inflammation by blocking chemicals (prostaglandins) in the body that cause swelling and pain.
• Rizatriptan: This drug works on serotonin receptors in the brain, causing blood vessels to narrow and stopping the pain signals that trigger migraine symptoms.

By combining these two medicines, Symbravo reduces inflammation and directly treats migraine pain, offering a two-way attack for better results.

What Did the Clinical Trials Show?

Symbravo was tested in large groups of people with migraine in clinical trials called MOMENTUM and INTERCEPT. The results were impressive:

• Many patients experienced pain relief within 2 hours of taking a dose.
• In some trials, 50% of attacks ended with pain relief at 2 hours, compared with only 16% among patients receiving a placebo.
• Most people didn’t need extra “rescue” medication for pain after taking Symbravo.

In another study, among people who didn’t respond well to other migraine drugs (such as CGRP inhibitors), using Symbravo led to relief in over half of cases, along with improvements in quality of life, daily functioning, and the ability to return to normal activities quickly.

What Are the Common Side Effects and Risks?

It’s important for the migraine community to understand both the benefits and potential risks. Like all medicines, Symbravo can cause side effects. The most common are:

• Dizziness
• Tiredness
• Sleepiness
• Weakness

Most mild side effects go away after a short time. However, Symbravo does have a “black box warning,” which is the strongest type of FDA warning for a medication. According to the warning, taking Symbravo can increase your risk of:

• Heart attack and stroke, especially for people with heart disease or multiple risk factors
• Serious stomach and intestinal problems like ulcers or bleeding, which can happen with little or no warning
• Allergic reactions, sometimes severe or life-threatening

Some people should NOT take Symbravo, including those with:

• History of heart disease, stroke, or blood vessel problems
• Uncontrolled high blood pressure
• Recent heart surgery (like bypass surgery)
• Allergy to NSAIDs or triptans

Symbravo should not be used in children or taken together with certain other drugs, like other triptans, NSAIDs, or some antidepressants (MAOIs, SSRIs, SNRIs). Tell your doctor about every medicine or supplement you take, as well as your complete health history, before starting Symbravo.

How Should the Migraine Community Use and View Symbravo?

Symbravo is not a cure for migraine, but it does offer a new and much-needed tool. This need is especially true for adults who haven’t found relief from other treatments in their migraine treatment toolbox. Symbravo is intended for use during an attack, and the single-tablet dose is simple and convenient. For people who have struggled with limited options or who need faster, longer-lasting results, Symbravo offers new hope in a disease landscape that desperately needs it.

The company behind Symbravo also has support programs, such as “Symbravo On My Side,” to help with costs and answer patient questions. So if you have insurance or need help paying for this medication, ask your doctor or pharmacist about these resources. And remember, insurance companies often deny coverage for a new medication the first time a prescription is written for it. But a denial is often something that can be appealed successfully and overturned – so bear in mind that “no” doesn’t necessarily mean a medication is out of reach for you! Explore how to work with your insurance company and medical team to help with approvals here.

What Does Symbravo Mean for the Future of Migraine Care?

The arrival of Symbravo means there are now more options for the migraine community than ever before. Its dual-action approach addresses both the inflammation and the neurological causes of migraine, and clinical studies show many people can get back to normal life faster after using it. However, since serious side effects are possible, it is crucial to use Symbravo exactly as your doctor prescribes and to be open about all your medical conditions.

If you’ve struggled to find the right migraine medication, talk to your medical team about Symbravo and whether it might be a good option for you.

LET US KNOW!

Have you tried Symbravro? If so, did it help stop your migraine attack? If not, would you like to discuss this medication with your doctor?

Note: This article is for educational purposes and does not take the place of medical advice from your medical team. Please discuss any new treatments with your doctor

References

Axsome Therapeutics. (2025). Symbravo (meloxicam and rizatriptan) [Prescribing Information]. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215431s000lbl.pdf

“F. Auby Watson BSN  used PerplexityAI to help structure this blog from her notes. The content and core ideas were her own, while PerplexityAI assisted with organization and presentation.”